Puymirat E, Simon T, Steg PG, et al. Association of changes in clinical characteristics and management with improvement in survival among patients with ST-elevation myocardial infarction. JAMA. 2012;308:998–1006.

Article  CAS  PubMed  Google Scholar 

Krumholz HM, Wang Y, Chen J, et al. Reduction in acute myocardial infarction mortality in the United States: risk-standardized mortality rates from 1995–2006. JAMA. 2009;302:767–73.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yeh RW, Sidney S, Chandra M, Sorel M, Selby JV, Go AS. Population trends in the incidence and outcomes of acute myocardial infarction. N Engl J Med. 2010;362:2155–65.

Article  CAS  PubMed  Google Scholar 

Natsuaki M, Sonoda S, Yoshioka G, et al. Antiplatelet therapy after percutaneous coronary intervention: current status and future perspectives. Cardiovasc Interv Ther. 2022;37:255–63.

Article  PubMed  Google Scholar 

Ozaki Y, Hara H, Onuma Y, et al. CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) update 2022. Cardiovasc Interv Ther. 2022;37:1–34.

Article  PubMed  PubMed Central  Google Scholar 

Kuramitsu S, Sonoda S, Ando K, et al. Drug-eluting stent thrombosis: current and future perspectives. Cardiovasc Interv Ther. 2021;36:158–68.

Article  PubMed  Google Scholar 

Ng VG, Lansky AJ, Meller S, et al. The prognostic importance of left ventricular function in patients with ST-segment elevation myocardial infarction: the HORIZONS-AMI trial. Eur Heart J Acute Cardiovasc Care. 2014;3:67–77.

Article  PubMed  PubMed Central  Google Scholar 

Granger CB, Goldberg RJ, Dabbous O, et al. Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med. 2003;163:2345–53.

Article  PubMed  Google Scholar 

Morrow DA, Antman EM, Parsons L, et al. Application of the TIMI risk score for ST-elevation MI in the National Registry of Myocardial Infarction 3. JAMA. 2001;286:1356–9.

Article  CAS  PubMed  Google Scholar 

Kimura K, Kimura T, Ishihara M, et al. JCS 2018 guideline on diagnosis and treatment of acute coronary syndrome. Circ J. 2019;83:1085–196.

Article  CAS  PubMed  Google Scholar 

Ibanez B, James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39:119–77.

Article  PubMed  Google Scholar 

Byrne RA, Rossello X, Coughlan JJ, et al. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J. 2023;44:3720–826.

Article  CAS  PubMed  Google Scholar 

Shimizu A. What are the most useful predictors of cardiac mortality in patients post myocardial infarction? Circ J. 2013;77:319–20.

Article  PubMed  Google Scholar 

Nienhuis MB, Ottervanger JP, Dambrink JH, et al. Comparative predictive value of infarct location, peak CK, and ejection fraction after primary PCI for ST elevation myocardial infarction. Coron Artery Dis. 2009;20:9–14.

Article  PubMed  Google Scholar 

Brooks GC, Lee BK, Rao R, et al. Predicting persistent left ventricular dysfunction following myocardial infarction: the PREDICTS study. J Am Coll Cardiol. 2016;67:1186–96.

Article  PubMed  PubMed Central  Google Scholar 

Chew DS, Wilton SB, Kavanagh K, Southern DA, Tan-Mesiatowsky LE, Exner DV. Left ventricular ejection fraction reassessment post-myocardial infarction: current clinical practice and determinants of adverse remodeling. Am Heart J. 2018;198:91–6.

Article  PubMed  Google Scholar 

Gajarsa JJ, Kloner RA. Left ventricular remodeling in the post-infarction heart: a review of cellular, molecular mechanisms, and therapeutic modalities. Heart Fail Rev. 2011;16:13–21.

Article  PubMed  Google Scholar 

Kuga K, Yamasaki H, Hattori A, et al. Prognosis of myocardial infarction with left ventricular dysfunction in the coronary revascularization era. Subanalysis of the Japanese Coronary Artery Disease (JCAD) Study. Circ J. 2014;78:2483–91.

Article  CAS  PubMed  Google Scholar 

De Luca G, Suryapranata H, Ottervanger JP, Antman EM. Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts. Circulation. 2004;109:1223–5.

Article  PubMed  Google Scholar 

Bolognese L, Cerisano G. Early predictors of left ventricular remodeling after acute myocardial infarction. Am Heart J. 1999;138:S79-83.

Article  CAS  PubMed  Google Scholar 

Cohn JN, Ferrari R, Sharpe N. Cardiac remodeling–concepts and clinical implications: a consensus paper from an international forum on cardiac remodelling. Behalf of an international forum on cardiac remodeling. J Am Coll Cardiol. 2000;35:569–82.

Article  CAS  PubMed  Google Scholar 

Wilton SB, Bennett MT, Parkash R, et al. Variability in reassessment of left ventricular ejection fraction after myocardial infarction in the acute myocardial infarction quality assurance canada study. JAMA Netw Open. 2021;4:e2136830.

Article  PubMed  PubMed Central  Google Scholar 

Yoshioka G, Tanaka A, Watanabe N, et al. Prognostic impact of incident left ventricular systolic dysfunction after myocardial infarction. Front Cardiovasc Med. 2022;9:1009691.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dargie HJ. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial. Lancet. 2001;357:1385–90.

Article  CAS  PubMed  Google Scholar 

Miller CD, Roe MT, Mulgund J, et al. Impact of acute beta-blocker therapy for patients with non-ST-segment elevation myocardial infarction. Am J Med. 2007;120:685–92.

Article  CAS  PubMed  Google Scholar 

Bangalore S, Makani H, Radford M, et al. Clinical outcomes with β-blockers for myocardial infarction: a meta-analysis of randomized trials. Am J Med. 2014;127:939–53.

Article  CAS  PubMed  Google Scholar 

Singh K, Hibbert B, Singh B, et al. Meta-analysis of admission hyperglycaemia in acute myocardial infarction patients treated with primary angioplasty: a cause or a marker of mortality? Eur Heart J Cardiovasc Pharmacother. 2015;1:220–8.

Article  PubMed  Google Scholar 

Pfeffer MA, Braunwald E, Moyé LA, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med. 1992;327:669–77.

Article  CAS  PubMed  Google Scholar 

Huikuri HV, Castellanos A, Myerburg RJ. Sudden death due to cardiac arrhythmias. N Engl J Med. 2001;345:1473–82.

Article  CAS  PubMed  Google Scholar 

Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352:225–37.

Article  CAS  PubMed  Google Scholar 

Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med. 1999;341:1882–90.

Article  CAS  PubMed  Google